National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 7) (PB 91 of 2015)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
 
PB 91 of 2015
National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 7)
National Health Act 1953
I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated                                          24 September                      2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 7).
            (2)        This Instrument may also be cited as PB 91 of 2015.
2          Commencement
            This Instrument commences on 1 October 2015.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, omit entry for Bleomycin
[2] Schedule 1, omit entry for Bupropion
[3] Schedule 1, omit entry for Fluvastatin
[4] Schedule 1, entry for Gliclazide
omit from the column headed “Claimed Price”:          8.31        substitute:             8.55
[5] Schedule 1, entry for Indapamide
omit from the column headed “Claimed Price”:          10.46     substitute:             10.97
[6] Schedule 1, after entry for Lamotrigine in the form Tablet 200 mg
insert:
Lansoprazole
Tablet 15 mg (orally disintegrating)
Oral
Zoton FasTabs
28
5.40
9.12

 
Tablet 30 mg (orally disintegrating)
Oral
Zoton FasTabs
28
9.70
13.42

[7] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 20 mg
omit from the column headed “Claimed Price”:          10.26     substitute:             10.69
[8] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 40 mg
omit from the column headed “Claimed Price”:          18.59     substitute:             19.02
[9] Schedule 1, after entry for Perindopril in the form Tablet containing perindopril arginine 2.5 mg [Brand: PREXUM 2.5]
insert:
Perindopril with amlodipine
Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)
Oral
Coveram 5/5
30
16.73
18.55

 
Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)
Oral
Coveram 5/10
30
22.67
27.27

 
Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)
Oral
Coveram 10/5
30
21.45
23.26

 
Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)
Oral
Coveram 10/10
30
27.37
29.18

 

Related Laws